As of 2026-05-22, the Intrinsic Value of Well Lead Medical Co Ltd (603309.SS) is 12.43 CNY. This 603309.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 13.52 CNY, the upside of Well Lead Medical Co Ltd is -8.10%.
The range of the Intrinsic Value is 9.26 - 18.67 CNY
Based on its market price of 13.52 CNY and our intrinsic valuation, Well Lead Medical Co Ltd (603309.SS) is overvalued by 8.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 9.26 - 18.67 | 12.43 | -8.1% |
| DCF (Growth 10y) | 16.25 - 31.68 | 21.48 | 58.9% |
| DCF (EBITDA 5y) | 36.23 - 55.83 | 46.86 | 246.6% |
| DCF (EBITDA 10y) | 42.41 - 70.48 | 56.61 | 318.7% |
| Fair Value | 1.33 - 1.33 | 1.33 | -90.20% |
| P/E | 7.62 - 13.04 | 9.94 | -26.5% |
| EV/EBITDA | 8.59 - 14.85 | 11.91 | -11.9% |
| EPV | (0.14) - 0.19 | 0.03 | -99.8% |
| DDM - Stable | 1.82 - 4.50 | 3.16 | -76.7% |
| DDM - Multi | 15.65 - 25.17 | 18.96 | 40.2% |
| Market Cap (mil) | 3,946.08 |
| Beta | 0.82 |
| Outstanding shares (mil) | 291.87 |
| Enterprise Value (mil) | 4,329.02 |
| Market risk premium | 6.13% |
| Cost of Equity | 11.26% |
| Cost of Debt | 5.00% |
| WACC | 10.48% |